Providence Alaska Medical Center — Anchorage, Alaska

Public research footprint of Providence Alaska Medical Center, compiled from the ClinicalTrials.gov public registry.

367

Registered studies

202

Active

Recruiting now

134

Completed

Stopped or withdrawn

Most-studied conditions

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Stage IIIB Lung Cancer AJCC v8 · Lung Non-Squamous Non-Small Cell Carcinoma

Recently updated registry entries

NCT02196181 — Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer… (Active Not Recruiting)
NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)
NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Providence Alaska Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.